Why standard health check-ups miss the metabolic picture
Annual health check-ups in India typically include a complete blood count, a basic lipid panel (total cholesterol, LDL, HDL, triglycerides), liver enzymes, kidney function, and blood glucose. This is a reasonable screening set. It catches anaemia, hepatitis, early kidney disease, and obvious glucose abnormalities.
What it typically misses: the early metabolic signals that precede type 2 diabetes by years or decades, and the cardiovascular risk factors that are elevated long before LDL is abnormal.
A targeted metabolic panel goes further — not by being more expensive, but by being more specific to the metabolic questions that matter for a patient managing weight or at risk for metabolic disease.
Test 1: Fasting insulin and HOMA-IR
Fasting glucose tells you whether glucose regulation is already impaired. Fasting insulin tells you how hard the pancreas is working to maintain that glucose level.
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated as: (fasting glucose in mmol/L × fasting insulin in mIU/L) / 22.5. A value above 2.5–3.0 in the Indian population is generally considered to indicate significant insulin resistance.
Many patients have a fasting glucose that is technically normal (below 100 mg/dL) while their fasting insulin is already elevated, producing a HOMA-IR of 4 or higher. This is the compensated phase of insulin resistance — the body is succeeding, but at a metabolic cost. Identifying it early creates the longest intervention window.
Test 2: HbA1c
HbA1c reflects average blood glucose over the previous two to three months, because glucose binds irreversibly to haemoglobin at a rate proportional to ambient glucose levels. It is a more reliable indicator of glucose metabolism than a single fasting glucose measurement, which can be affected by recent meals, stress, and timing.
Reference ranges:
- Below 5.7%: normal
- 5.7–6.4%: prediabetes (a critical intervention window)
- 6.5% and above: diabetes
An HbA1c of 5.9% in an asymptomatic 34-year-old Indian adult is not "fine" — it is early prediabetes in a patient with a decade or more of runway for intervention. Understanding this number in context changes what is done with it.
Test 3: Triglycerides and HDL
The ratio of triglycerides to HDL is one of the most informative metabolic markers available from a standard lipid panel. An elevated triglyceride-to-HDL ratio correlates with insulin resistance and small dense LDL particles — the particles most associated with atherosclerosis.
In Indian patients:
- Triglycerides above 150 mg/dL are a metabolic concern
- HDL below 40 mg/dL in men and below 50 mg/dL in women indicates low protective lipoprotein
- A triglyceride-to-HDL ratio above 3.0 (in mg/dL units) suggests insulin resistance regardless of whether fasting glucose is elevated
This pattern — elevated triglycerides, low HDL, and elevated insulin — is the metabolic signature of visceral adiposity and insulin resistance in Indian adults.
Test 4: Liver enzymes (ALT)
Alanine aminotransferase (ALT) is an enzyme primarily found in liver cells. Elevated ALT indicates hepatic inflammation — most commonly, in an Indian adult with metabolic risk, non-alcoholic fatty liver disease (NAFLD).
NAFLD is now the most common liver disease in India, with a prevalence of 9–32% in the general population and substantially higher rates in metabolically at-risk groups. It is strongly associated with insulin resistance, central obesity, and dyslipidaemia.
An ALT consistently above 40 U/L in a patient with metabolic risk deserves evaluation. An ultrasound of the liver can confirm fatty infiltration. NAFLD is reversible in early stages with metabolic intervention — which makes early identification clinically actionable.
Test 5: Uric acid
Serum uric acid is elevated in a significant proportion of metabolically at-risk Indian adults. Hyperuricaemia is independently associated with insulin resistance, hypertension, and cardiovascular risk — not only with gout.
In the context of a metabolic assessment, elevated uric acid (above 6 mg/dL in women and 7 mg/dL in men) is a marker of metabolic stress. It often responds to the same interventions that improve insulin sensitivity.
Putting the panel together
The value of a metabolic panel is in its pattern, not in any single number. A patient with fasting glucose of 92 mg/dL (normal), HbA1c of 5.8% (borderline), HOMA-IR of 4.2 (elevated), triglycerides of 180 mg/dL (elevated), HDL of 38 mg/dL (low), and ALT of 52 U/L (elevated) has a coherent metabolic picture — early insulin resistance with hepatic involvement and dyslipidaemia — that would be completely invisible from a standard health check-up. The management of that patient looks very different from a patient with identical fasting glucose and no other metabolic abnormalities.
A doctor reviewing this panel is not just checking boxes. They are reading a metabolic narrative — one that often explains years of unsuccessful weight management attempts and creates the basis for an intervention plan that is specific to the patient's biology.